EP Patent

EP3281941B1 — Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid

Assigned to Zentiva KS · Expires 2019-07-24 · 7y expired

What this patent protects

Patent listed against Aloprim.

Drugs covered by this patent

Patent Metadata

Patent number
EP3281941B1
Jurisdiction
EP
Classification
—
Expires
2019-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Zentiva KS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.